Corcept Therapeutics Incorporated (CORT)

Debt-to-equity ratio

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Long-term debt	US$ in thousands	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Total stockholders’ equity	US$ in thousands	506,705	461,679	421,614	529,584	501,842	473,364	442,326	407,811	375,806	540,229	522,675	510,802	523,338	489,680	453,698	409,489	371,182	334,376	298,053	285,755
Debt-to-equity ratio		0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

December 31, 2023 calculation

Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $506,705K
= 0.00

The debt-to-equity ratio of Corcept Therapeutics Inc has consistently been 0.00 throughout the past eight quarters, indicating that the company carries no debt on its balance sheet relative to its equity. A debt-to-equity ratio of 0.00 suggests that the company is not reliant on external borrowing to finance its operations and that it has a strong financial position with a low level of financial risk. This could be seen as a positive sign for investors, as lower debt levels generally imply greater stability and flexibility for the company in managing its financial obligations.